Stage III Colon Cancer

Also known as: Colon Cancer Stage III / Stage 3 Colon cancer / Colon carcinoma Dukes C / Carcinoma of colon, stage III (finding) / Colon cancer Dukes C / Colon carcinoma stage III / Carcinoma colon Dukes C / Colonic cancer stage III

Drug	Drug Name	Drug Description
DB01101	Capecitabine	A nucleoside metabolic inhibitor indicated to treat different gastrointestinal, including pancreatic cancer, and breast cancer.
DB00526	Oxaliplatin	A platinum based chemotherapy agent used to treat carcinoma of the colon or rectum or stage III colon cancer.

Drug	Drug Name	Target	Type
DB01101	Capecitabine	Thymidylate synthase	target
DB01101	Capecitabine	Thymidine phosphorylase	enzyme
DB01101	Capecitabine	Cytidine deaminase	enzyme
DB01101	Capecitabine	Liver carboxylesterase 1	enzyme
DB01101	Capecitabine	Cytochrome P450 2C9	enzyme
DB01101	Capecitabine	DNA	target
DB01101	Capecitabine	RNA	target
DB01101	Capecitabine	Serum albumin	carrier
DB01101	Capecitabine	Uridine phosphorylase 1	enzyme
DB01101	Capecitabine	Uridine phosphorylase 2	enzyme
DB00526	Oxaliplatin	DNA	target
DB00526	Oxaliplatin	Solute carrier family 22 member 2	transporter
DB00526	Oxaliplatin	High affinity copper uptake protein 1	transporter
DB00526	Oxaliplatin	Solute carrier family 22 member 3	transporter
DB00526	Oxaliplatin	ATP-binding cassette sub-family G member 2	transporter
DB00526	Oxaliplatin	Glutathione S-transferase theta-1	enzyme
DB00526	Oxaliplatin	Metallothionein-1A	enzyme
DB00526	Oxaliplatin	Metallothionein-2	enzyme
DB00526	Oxaliplatin	Myeloperoxidase	enzyme
DB00526	Oxaliplatin	Superoxide dismutase [Cu-Zn]	enzyme
DB00526	Oxaliplatin	Glutathione S-transferase P	enzyme
DB00526	Oxaliplatin	Glutathione S-transferase Mu 1	enzyme
DB00526	Oxaliplatin	NAD(P)H dehydrogenase [quinone] 1	enzyme
DB00526	Oxaliplatin	Canalicular multispecific organic anion transporter 1	transporter
DB00526	Oxaliplatin	Copper-transporting ATPase 2	transporter
DB00526	Oxaliplatin	Copper-transporting ATPase 1	transporter
DB00526	Oxaliplatin	Serum albumin	carrier

Drug	Drug Name	Phase	Status	Count
DB12442	Alvespimycin	1	Completed	1
DB00112	Bevacizumab	1	Active Not Recruiting	1
DB11967	Binimetinib	1	Terminated	1
DB01373	Calcium	1	Active Not Recruiting	1
DB01101	Capecitabine	1	Completed	1
DB00958	Carboplatin	1	Completed	1
DB00002	Cetuximab	1	Completed	1
DB01254	Dasatinib	1	Active Not Recruiting	1
DB15631	Edodekin alfa	1	Completed	1
DB11718	Encorafenib	1	Terminated	1
DB00544	Fluorouracil	1	Active Not Recruiting	1
DB00544	Fluorouracil	1	Completed	1
DB00762	Irinotecan	1	Completed	1
DB00650	Leucovorin	1	Active Not Recruiting	1
DB00650	Leucovorin	1	Completed	1
DB11596	Levoleucovorin	1	Active Not Recruiting	1
DB15483	Modified vaccinia ankara	1	Completed	1
DB15721	Natural Killer Cell	1	Completed	1
DB09035	Nivolumab	1	Terminated	1
DB00526	Oxaliplatin	1	Active Not Recruiting	1
DB00526	Oxaliplatin	1	Completed	1
DB01229	Paclitaxel	1	Completed	1
DB11870	RG-4733	1	Completed	1
DB02709	Resveratrol	1	Completed	1
DB00020	Sargramostim	1	Completed	1
DB00398	Sorafenib	1	Completed	1
DB00072	Trastuzumab	1	Completed	1
DB02546	Vorinostat	1	Completed	1
DB00112	Bevacizumab	1 / 2	Completed	1
DB00002	Cetuximab	1 / 2	Completed	2
DB00477	Chlorpromazine	1 / 2	Withdrawn	1
DB00530	Erlotinib	1 / 2	Completed	1
DB00762	Irinotecan	1 / 2	Completed	2
DB06366	Pertuzumab	1 / 2	Completed	1
DB06436	Semaxanib	1 / 2	Completed	1
DB11595	Atezolizumab	2	Not Yet Recruiting	1
DB01101	Capecitabine	2	Not Yet Recruiting	1
DB01101	Capecitabine	2	Recruiting	1
DB14086	Cianidanol	2	Terminated	1
DB00544	Fluorouracil	2	Active Not Recruiting	1
DB00544	Fluorouracil	2	Not Yet Recruiting	1
DB00544	Fluorouracil	2	Recruiting	1
DB14307	Green tea leaf	2	Terminated	1
DB00762	Irinotecan	2	Recruiting	1
DB00650	Leucovorin	2	Active Not Recruiting	1
DB00650	Leucovorin	2	Not Yet Recruiting	1
DB00650	Leucovorin	2	Recruiting	1
DB11596	Levoleucovorin	2	Recruiting	1
DB00526	Oxaliplatin	2	Active Not Recruiting	1
DB00526	Oxaliplatin	2	Not Yet Recruiting	1
DB00526	Oxaliplatin	2	Recruiting	1
DB01266	Sinecatechins	2	Terminated	1
DB09343	Tipiracil	2	Recruiting	1
DB00072	Trastuzumab	2	Recruiting	1
DB00432	Trifluridine	2	Recruiting	1
DB11652	Tucatinib	2	Recruiting	1
DB00544	Fluorouracil	2 / 3	Enrolling by Invitation	1
DB00650	Leucovorin	2 / 3	Enrolling by Invitation	1
DB00526	Oxaliplatin	2 / 3	Enrolling by Invitation	1
DB11945	Avelumab	3	Terminated	1
DB00112	Bevacizumab	3	Completed	1
DB00112	Bevacizumab	3	Terminated	1
DB11967	Binimetinib	3	Recruiting	1
DB01101	Capecitabine	3	Not Yet Recruiting	1
DB01101	Capecitabine	3	Terminated	1
DB00002	Cetuximab	3	Completed	1
DB00002	Cetuximab	3	Recruiting	1
DB11718	Encorafenib	3	Recruiting	1
DB00544	Fluorouracil	3	Completed	5
DB00544	Fluorouracil	3	Not Yet Recruiting	1
DB00544	Fluorouracil	3	Recruiting	1
DB00544	Fluorouracil	3	Terminated	1
DB00762	Irinotecan	3	Completed	2
DB00762	Irinotecan	3	Recruiting	1
DB00650	Leucovorin	3	Completed	4
DB00650	Leucovorin	3	Not Yet Recruiting	1
DB00650	Leucovorin	3	Recruiting	1
DB00650	Leucovorin	3	Terminated	1
DB00848	Levamisole	3	Completed	1
DB09035	Nivolumab	3	Recruiting	1
DB00526	Oxaliplatin	3	Completed	3
DB00526	Oxaliplatin	3	Not Yet Recruiting	1
DB00526	Oxaliplatin	3	Terminated	1
DB01269	Panitumumab	3	Completed	1
DB06366	Pertuzumab	3	Recruiting	1
DB00072	Trastuzumab	3	Recruiting	1
DB05296	Motexafin lutetium	Not Available	Terminated	1
DB09327	Tegafur-uracil	Not Available	Active Not Recruiting	1